United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - bordetella bronchiseptica - suspension for injection - inactivated bacterial vaccine - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - bordetella bronchiseptica - suspension for injection - inactivated bacterial vaccine - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - bordetella bronchiseptica - suspension for injection - inactivated bacterial vaccine - dogs

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - inactivated leptospira strains: l. interrogans serogroup canicola serovar portland-vere (strain ca-12-000); l. interrogans serogroup icterohaemorrhagiae serovar copenhageni (strain ic-02-001); l. interrogans serogroup australis serovar bratislava (strain as-05-073); l. kirschneri serogroup grippotyphosa serovar dadas (strain gr-01-005) - immunologicals for canidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - dogs - for active immunisation of dogs against:l. interrogans serogroup canicola serovar canicola to reduce infection and urinary excretion;l. interrogans serogroup icterohaemorrhagiae serovar copenhageni to reduce infection and urinary excretion;l. interrogans serogroup australis serovar bratislava to reduce infection;l. kirschneri serogroup grippotyphosa serovar bananal/lianguang to reduce infection and urinary excretion.

European Union - English - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, hepatitis b surface antigen, bordetella pertussis (inactivated), tetanus toxoid - hepatitis b; tetanus; immunization; whooping cough; diphtheria - vaccines - tritanrix hepb is indicated for active immunisation against diphtheria, tetanus, pertussis and hepatitis b (hbv) in infants from six weeks onwards (see section 4.2).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - streptococcus equi; thiomersal - misc. vaccines or anti sera - streptococcus equi vaccine-microbial active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - strangles | vaccine | equine rotavirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - thiomersal; selenium; vitamin b12a = hydroxocobalamin; clostridium chauvoei - formol culture; clostridium novyi type b; cla = corynebacterium pseudotuberculosis ovis; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid - misc. vaccines or anti sera - thiomersal mercury active 0.1 mg/ml; selenium mineral-selenium active 1.0 mg/ml; vitamin b12a = hydroxocobalamin vitamin-b12 active 2.0 mg/ml; clostridium chauvoei - formol culture vaccine-microbial active 0.0 u; clostridium novyi type b vaccine-microbial active 0.0 u; cla = corynebacterium pseudotuberculosis ovis vaccine-microbial active 0.0 u; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 u; clostridium septicum - toxoid vaccine-toxoid active 0.0 u; clostridium tetani - toxoid vaccine-toxoid active 0.0 u - immunotherapy - lamb | sheep | sheep ram (male) | ewe | hogget | lamb | ovine | ram | weaner | wether - black disease | blackleg | caseous lymphadenitis (cheesy gland) | enterotoxaemia (pulpy kidney) | malignant oedema | swelled head | tetanus | vitamin b12 deficiency | white muscle disease | anaemia | clostridium perfringens type d | cobalt deficiency | selenium deficiency | stiff lamb disease | subacute enzootic muscular dys | tetanus vaccination

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - thiomersal; selenium as sodium selenate; clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid - parenteral liquid/solution/suspension - thiomersal mercury active 0.13 mg/ml; selenium as sodium selenate mineral-selenium active 0.5 mg/ml; clostridium chauvoei - toxoid vaccine-toxoid active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 3.5 iu/ml; clostridium perfringens type d toxoid vaccine-toxoid active 5.0 iu/ml; clostridium septicum - toxoid vaccine-toxoid active 2.5 iu/ml; clostridium tetani - toxoid vaccine-toxoid active 2.5 iu/ml - immunotherapy - lamb | ovine - black disease | blackleg | enterotoxaemia (pulpy kidney) | malignant oedema | selenium deficiency | tetanus | unthriftiness | white muscle disease | clostridium perfringens type d | ill - thrift | selenium deficiency | selenium responsive ill-thrift | stiff lamb disease | subacute enzootic muscular dys | tetanus vaccination | white muscle disease

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

sad -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - bovine rotavirus (ncdv); clostridium perfringens type c toxoid; escherichia coli k99 pilus antigens; clostridium perfringens type d toxoid; bovine coronavirus (inactivated) - misc. vaccines or anti sera - bovine rotavirus (ncdv) biological-virus active 1.0 rp; clostridium perfringens type c toxoid vaccine-toxoid active 10.0 iu/ml; escherichia coli k99 pilus antigens vaccine-microbial active 1.0 rp; clostridium perfringens type d toxoid vaccine-toxoid active 2.0 iu/ml; bovine coronavirus (inactivated) vaccine-viral active 1.0 rp - immunotherapy - cow | healthy pregnant heifer | bovine | female cattle - bovine rotaviruses | neonatal calf diarrhea | neonatal enterotoxemia | raise colostral antibodies | against bovine rotavirus and | coronavirus | enterotoxigenic e.coli pilus | g6 and g10 | type k99